Skip to main content
. Author manuscript; available in PMC: 2014 Dec 9.
Published in final edited form as: Pharm Res. 2009 Jun 16;26(8):1986–1994. doi: 10.1007/s11095-009-9914-2

Table 3.

Extent of acylation inhibition (%) afforded by divalent cations

Time
(days)
Formulation #
5 6 7 8
7 68.5±2.4 69.1±1.3 73.7±3.8 74.2±2.6
14 53.6±1.3 61.5±4.1 62.0±2.5 65.7±3.7
21 53.2±3.8 53.3±3.1 62.7±0.8 70.9±3.6
28 37.3±3.7 40.5±2.2 57.8±2.0 61.4±3.0

Inhibition extent was calculated by [acylated octreotide content in microspheres without additive(%) – acylated octreotide content in microsphere with salt additive(%)]/acylated octreotide content in microspheres without additive(%)